CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (258,226)	$ (72,105)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	32,902	34,360
Deferred income taxes	(2,625)	(18,764)
Equity in net loss of equity-method investees	1,709	2,371
Stock-based compensation, net	9,422	10,135
Goodwill impairment	201,518	0
Long-lived asset and intangibles impairment	42,029	70,786
Loss on sale of assets	2,202	62
Other non-cash items, net	773	944
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable	(1,361)	(30,672)
Inventories	(10,605)	27,432
Other current assets	(8,279)	13,830
Other assets and liabilities	(561)	(4,466)
Accounts payable and accrued expenses	15,865	43,046
Net cash provided by operating activities	24,763	76,959
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(19,060)	(24,769)
Proceeds from termination of net investment hedges	2,363	0
Proceeds from sale of assets	13,773	1,520
Investments and joint ventures, net	2,570	0
Net cash used in investing activities	(354)	(23,249)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	156,000	152,000
Repayments under bank revolving credit facility	(186,000)	(197,000)
Repayments under term loan	(5,625)	(5,625)
Payments of other debt, net	(21)	(3,875)
Employee shares withheld for taxes	(1,381)	(1,600)
Proceeds from termination of fair value hedge	552	0
Net cash used in financing activities	(36,475)	(56,100)
Effect of exchange rate changes on cash	2,184	(1,425)
Net decrease in cash and cash equivalents	(9,882)	(3,815)
Cash and cash equivalents at beginning of period	54,307	53,364
Cash and cash equivalents at end of period	$ 44,425	$ 49,549